Early kinetics of the transcriptional response of human leukocytes to staphylococcal superantigenic enterotoxins A and G

Microbial Pathogenesis

Volumn 47, Issue 3, 2009, Pages 171-176

  Dauwalder, Olivier ^a,b,c   Pachot, Alexandre ^d   Cazalis, Marie Angélique ^d   Paye, Malick ^d   Faudot, Caroline ^d   Badiou, Cédric ^a   Mougin, Bruno ^d   Vandenesch, François ^a,b,c   Etienne, Jerome ^a,b,c   Lina, Gerard ^a,b,c   Monneret, Guillaume ^b,d  

^a UNIVERSITÉ LYON 1   (France)

^b INSERM   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

egc cluster; Inflammation; Microarray; Septic shock; Staphylococcus aureus; Superantigen

Indexed keywords

AUTACOID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN G; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; GENE CLUSTER; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MICROARRAY ANALYSIS; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE;

CELLS, CULTURED; CYTOKINES; ENTEROTOXINS; GENE EXPRESSION; HUMANS; KINETICS; LEUKOCYTES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 68249158457     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.07.001     Document Type: Article

References (46)

1. Angus D.C., and Wax R.S. Epidemiology of sepsis: an update. Crit Care Med 29 (2001) 109-116
2. Brun-Buisson C., Meshaka P., Pinton P., and Vallet B. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30 (2004) 580-588
3. Brun-Buisson C., Roudot-Thoraval F., Girou E., Grenier-Sennelier C., and Durand-Zaleski I. The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis. Intensive Care Med 29 (2003) 1464-1471
4. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34 (2006) 344-353
5. Zeni F., Freeman B., and Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25 (1997) 1095-1100
6. Pugin J. Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp 280 (2007) 21-27
7. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63-78
8. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003) 138-150
9. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 339 (1998) 520-532
10. Thomas D., Chou S., Dauwalder O., and Lina G. Diversity in Staphylococcus aureus enterotoxins. Chem Immunol Allergy 93 (2007) 24-41
11. Peacock S.J., Moore C.E., Justice A., Kantzanou M., Story L., Mackie K., et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun 70 (2002) 4987-4996
12. Jarraud S., Peyrat M.A., Lim A., Tristan A., Bes M., Mougel C., et al. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol 166 (2001) 669-677
13. Lina G., Bohach G.A., Nair S.P., Hiramatsu K., Jouvin-Marche E., and Mariuzza R. Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis 189 (2004) 2334-2336
14. Descloux E., Perpoint T., Ferry T., Lina G., Bes M., Vandenesch F., et al. One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis 27 (2008) 37-43
15. Ferry T., Thomas D., Genestier A.L., Bes M., Lina G., Vandenesch F., et al. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis 41 (2005) 771-777
16. Proft T., and Fraser J.D. Bacterial superantigens. Clin Exp Immunol 133 (2003) 299-306
17. Thomas D., Dauwalder O., Brun V., Badiou C., Ferry T., Etienne J., et al. Staphylococcus aureus superantigens elicit redundant and extensive human Vbeta patterns. Infect Immun 77 (2009) 2043-2050
18. Dauwalder O., Thomas D., Ferry T., Debard A.L., Badiou C., Vandenesch F., et al. Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock. J Leukoc Biol. 80 (2006) 753-758
19. Ferry T., Perpoint T., Vandenesch F., and Etienne J. Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes. Curr Infect Dis Rep 7 (2005) 420-428
20. Torres B.A., Kominsky S., Perrin G.Q., Hobeika A.C., and Johnson H.M. Superantigens: the good, the bad, and the ugly. Exp Biol Med 226 (2001) 164-176
21. Mendis C., Das R., Hammamieh R., Royaee A., Yang D., Peel S., et al. Transcriptional response signature of human lymphoid cells to staphylococcal enterotoxin B. Genes Immun 6 (2005) 84-94
22. Hedrick J.A., Helms A., Vicari A., and Zlotnik A. Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10. Blood 91 (1998) 4242-4247
23. Schutyser E., Struyf S., and Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14 (2003) 409-426
24. Tikhonov I., Kitabwalla M., Wallace M., Malkovsky M., Volkman B., and Pauza C.D. Staphylococcal superantigens induce lymphotactin production by human CD4+ and CD8+ T cells. Cytokine 16 (2001) 73-78
25. Lebedeva T., Dustin M.L., and Sykulev Y. ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr Opin Immunol 17 (2005) 251-258
26. Labuda T., Wendt J., Hedlund G., and Dohlsten M. ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-activated human CD4+ T cells. Immunology 94 (1998) 496-502
27. Lina G., Cozon G., Ferrandiz J., Greenland T., Vandenesch F., and Etienne J. Detection of staphylococcal superantigenic toxins by a CD69-specific cytofluorimetric assay measuring T-cell activation. J Clin Microbiol. 36 (1998) 1042-1045
28. Eshima K., Choi Y., and Flavell R.A. CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A. Int Immunol 15 (2003) 817-826
29. Holtfreter S., and Broker B.M. Staphylococcal superantigens: do they play a role in sepsis?. Arch Immunol Ther Exp 53 (2005) 13-27
30. Yoshimura A., Naka T., and Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7 (2007) 454-465
31. Takahashi N., Hasegawa H., Komiyama M., Ohki T., Yada Y., Koike Y., et al. Selective excretion of anti-inflammatory cytokine interleukin-10 in a superantigen-inducing neonatal infectious disease. Cytokine 45 (2009) 39-43
32. Monneret G., Venet F., Pachot A., and Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 14 (2008) 64-78
33. Hotchkiss R.S., and Nicholson D.W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6 (2006) 813-822
34. Yang Y., Kim D., and Fathman C.G. Regulation of programmed cell death following T cell activation in vivo. Int Immunol 10 (1998) 175-183
35. Shinohara F., Sato K., Suzuki M., Takada H., Echigo S., and Rikiishi H. Role of caspase in CD80 expression of superantigen-stimulated monocytes. Int J Mol Med 14 (2004) 241-246
36. Grumann D., Scharf S.S., Holtfreter S., Kohler C., Steil L., Engelmann S., et al. Immune cell activation by enterotoxin gene cluster (egc)-encoded and non-egc superantigens from Staphylococcus aureus. J Immunol 181 (2008) 5054-5061
37. Benito Y., Kolb F.A., Romby P., Lina G., Etienne J., and Vandenesch F. Probing the structure of RNAIII, the Staphylococcus aureus agr regulatory RNA, and identification of the RNA domain involved in repression of protein A expression. RNA 6 (2000) 668-679
38. Pachot A., Blond J.L., Mougin B., and Miossec P. Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. J Biotechnol 114 (2004) 121-124
39. Pachot A., Monneret G., Voirin N., Leissner P., Venet F., Bohe J., et al. Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol 114 (2005) 61-69
40. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003) 249-264
41. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., and Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31 (2003) 15
42. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Genet Mol Biol 3 (2004) 3
43. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B.57 (1995) 289-300
44. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25 (2000) 25-29
45. Kanehisa M., and Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28 (2000) 27-30
46. Hosack D.A., Dennis Jr. G., Sherman B.T., Lane H.C., and Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol 4 (2003) 70